No associations were found between SETDB1 expression and NSCLC patients carrying mutations for neither the Epidermal Growth Factor Receptor (EGFR) nor the KRAS oncogenes (Table 2). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.